Liu Liming L - OmicsDI

Show results for

Unknown (13)
Proteomics (12)
Genomics (9)
Models (2)
Metabolomics (2)
Transcriptomics (1)

Organisms

Homo sapiens (15)
Mus musculus (2)
Ketogulonicigenium vulgare (1)

Repository

EGA (9)
iProX (5)
PAXDB (4)
pride (3)
BioModels (2)
MetaboLights (2)
biostudies-arrayexpress (1)

Tissue

Blood serum (2)
Blood cell (1)
Cell culture (1)
Macrophage (1)

Disease

Non-small cell lung carcinoma (1)

Technology Type

Mass Spectrometry (3)
Mass spectrometry (2)
Shotgun proteomics (2)
All-ion fragmentation (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2019 (5)
2024 (3)
2015 (2)
2025 (2)
2023 (2)
2022 (2)
2014 (1)

UNIPROT ID/AC

14310_ARATH (4)
14332_ARATH (4)
14333_ARATH (4)
14335_ARATH (4)
14337_ARATH (4)
14339_ARATH (4)
1A110_ARATH (4)
1A112_ARATH (4)
2A5A_ARATH (4)
2A5B_ARATH (4)
2A5D_ARATH (4)
2A5G_ARATH (4)
2A5Z_ARATH (4)
2AAA_ARATH (4)
2AAB_ARATH (4)
2AAG_ARATH (4)
2AB2A_ARATH (4)
2AB2B_ARATH (4)
2AB2E_ARATH (4)
2ABB_ARATH (4)
2SS2_ARATH (4)
3702.AT2G25210.1 (4)
3702.AT2G36485.1 (4)
3702.AT3G18270.1 (4)
3702.AT5G08670.1 (4)
3702.AT5G65770.2 (4)
3HID1_ARATH (4)
3HID2_ARATH (4)
3HID3_ARATH (4)
3HIDH_ARATH (4)

CHEBI ID

CHEBI:15354 (2)
CHEBI:16610 (2)
CHEBI:16811 (2)
CHEBI:16919 (2)
CHEBI:17148 (2)
CHEBI:17822 (2)
CHEBI:18257 (2)
CHEBI:25017 (2)
CHEBI:25094 (2)
CHEBI:26271 (2)
CHEBI:27266 (2)
CHEBI:27897 (2)
CHEBI:28300 (2)
CHEBI:29016 (2)
CHEBI:37024 (2)
CHEBI:10055 (1)
CHEBI:101085 (1)
CHEBI:1060 (1)
CHEBI:113542 (1)
CHEBI:116314 (1)
CHEBI:125471 (1)
CHEBI:131158 (1)
CHEBI:131456 (1)
CHEBI:131659 (1)
CHEBI:131690 (1)
CHEBI:132244 (1)
CHEBI:132837 (1)
CHEBI:133013 (1)
CHEBI:133066 (1)
CHEBI:133172 (1)

Metabolite Name

Aminoadipic acid (2)
Choline (2)
Creatine (2)
Methionine (2)
Proline (2)
Putrescine (2)
Spermidine (2)
Valine (2)
(+)-8'-hydroxyabscisic acid (1)
(-)-11-hydroxy-9,10-dihydrojasmonic acid 11-beta-d-glucoside (1)
(-)-lupinine (1)
(11z,14z)-eicosadienoylcarnitine (1)
(1s,2r)-1,2-dihydrodibenzo[b,d]thiophene-1,2-diol (1)
(1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,16-trimethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1~10,14~.0~3,5~]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2-methylpropanoate (1)
(2,7-dimethyloctahydro-1h-cyclopenta[c]pyridin-4-yl)methanol (1)
(2e)-2-[(4z)-5-(methylsulfanyl)-4-penten-2-yn-1-ylidene]-1,6-dioxaspiro[4.4]non-3-ene (1)
(2r,3s)-2-methylcitric acid (1)
(2s,3r,4e,8e)-3-hydroxy-2-[methyl(stearoyl)amino]-4,8-octadecadien-1-yl hydrogen sulfate (1)
(2s,3s,4s,5r,6s)-6-(hydroxymethyl)-5-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)-5-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl]oxy}tetrahydro-2h-pyran-2-yl]oxy}tetrahydro-2h-pyran-2,3,4,5-tetrol (1)
(2s,4ar,4br,6as,12bs,12cs,14as)-2-(2-hydroxy-2-propanyl)-12b,12c-dimethyl-3,4,5,6,6a,7,12,12b,12c,13,14,14a-dodecahydro-2h-chromeno[5',6':6,7]indeno[1,2-b]indole-4a(4bh)-carbaldehyde (1)
(2s,4s)-4-amino-2-hydroxy-2-methylpentanedioic acid (1)
(2s,4s)-pinnatanine (1)
(2z)-3-{5-[(4z)-5-(methylsulfanyl)-4-penten-2-yn-1-yl]-2-furyl}acrylaldehyde (1)
(2z,4z)-2-hydroxyhexa-2,4-dienoic acid (1)
(3-methyl-2-butenyl)-benzene (1)
(3s,5r,6s,7e,9x)-7-megastigmene-3,6,9-triol 9-glucoside (1)
(4-methylphenyl)acetaldehyde (1)
(4e,6e,d14:2) sphingosine (1)
(7s)-7-{[(2s)-9-hydroxy-2-isobutyl-3-oxo-2,3,9,9a-tetrahydro-1h-imidazo[1,2-a]indol-9-yl]methyl}-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione (1)
(9e,15e)-heptadec-9,15-trien-11,13-diyn-4-one (1)

IsPrivate

False (2)

Model Flag

Non Kinetic (2)

Modelling Approach

Constraint-based model (2)

Study type

Transcription profiling by array (1)

Release Date

2025 (3)
2024 (3)
2022 (2)
2021 (2)
2014 (1)
2023 (1)
2015 (1)
2026 (1)

Lab affiliation

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS-HKU Joint Laboratory of Metallomics on Health and Environment & CAS Center for Excellence in Nanoscience, Institute of High Energy Physics & National Center for Nanoscience and Technology of China, Chinese Academy of Sciences, Beijing 100049, P. R. China (1)
Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Institute of High Energy Physics, CAS (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Liming promotes the leaching of carbon and nitrogen in a double-cropped rice system.

Not available

S-EPMC12317146 | biostudies-literature

Liu2012 - Genome-scale metabolic network of Scheffersomyces stipitis (iTL885)

Liu2012 - Genome-scale metabolic network of Scheffersomyces stipitis (iTL885) This model is described in the article: A constraint-based model of Scheffersomyces stipitis for improved ethanol production. Liu T, Zou W, Liu L, Chen J. Biotechnol Biofuels 2012; 5(1): 72 Abstrac...

2015-07-30 | MODEL1507180026 | BioModels

Profiling of Serum N-glycosylation in Non-small-cell Lung Cancer

Aberrant serum N-glycan profiles have been observed in multiple cancers including non-small-cell lung cancer (NSCLC), yet the potential of N-glycans in the early diagnosis of NSCLC remains to be determined. Here, serum N-glycan profiles of 275 NSCLC patients and 309 healthy controls were characteriz...

ORGANISM(S): Homo sapiens (Human)

2023-11-23 | PXD040883 | Pride

A phosphatase-like nanomaterial promotes autophagy and reprograms macrophage for cancer immunotherapy

Macrophages are very plastic and play key roles in maintenance of tissue homeostasis. In cancer progression, macrophages also take parts through all the processes, from the initiation, progression, to the final tumor metastasis. Although energy deprivation and autophagy are widely used for cancer th...

ORGANISM(S): Mus musculus (Mouse)

2024-08-10 | PXD051695 | Pride

Raw264.7 Mice Phospho-proteins Lc-ms/ms

PTEN-L inhibits mitophagy and GSDME-dependent pyroptosis via Parkin dephosphorylation

Not available

S-SCDT-10_1038-S44319-026-00957-4 | biostudies-other

De novo biosynthesis of rubusoside and rebaudiosides in engineered yeasts.

Not available

S-EPMC9160076 | biostudies-literature

PRODH regultes naive pluripotency by influencing mitochondrial oxidative phosphorylation (Untargeted metabolomics)

Naïve human embryonic stem cells (hESCs) that resemble the pre-implantation epiblasts are fueled by a combination of aerobic glycolysis and oxidative phosphorylation, but their mitochondrial regulators are poorly understood. Here we report that, proline dehydrogenase (PRODH), a mitochondria-local...

2024-02-12 | MTBLS7840 | MetaboLights

Zou2012 - Genome-scale metabolic network of Ketogulonicigenium vulgare (iWZ663)

Zou2012 - Genome-scale metabolic network of Ketogulonicigenium vulgare (iWZ663) This model is described in the article: Genome-scale metabolic model of Helicobacter pylori 26695. Schilling CH, Covert MW, Famili I, Church GM, Edwards JS, Palsson BO. J. Bacteriol. 2002 Aug; 184(...

2015-07-30 | MODEL1507180039 | BioModels

Ketogulonicigenium vulgare cells: Acid-stressed vs. Control

Transcriptional profiling of K. vulgare cells, co-cultured with Bacillus megaterium, comparing control untreated cells with cells treated with pH 4.0 for 2 h. Differentially expressed genes in acid-stressed cells were analyzed. The aim was to investigate the mechanisms of K. vulgare in response to a...

ORGANISM(S): Ketogulonicigenium vulgare

2014-10-23 | E-GEOD-33105 | biostudies-arrayexpress

2022 Shandong Province university medical technical skills competition nursing track: An effective project to improve core competencies of nursing students.

Not available

S-EPMC10906172 | biostudies-literature

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

39 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

IsPrivate

Model Flag

Modelling Approach

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets